Horizon Megadeal: J&J Out, Experts Say Sanofi Could Have Edge On Amgen

Janssen has dropped out of the running to acquire Irish biotech Horizon, leaving Sanofi and Amgen to vie over the potential megadeal, with some observers identifying the former as the better fit.    

Two people running in race against sunset horizon background
Sanofi And Amgen Remain In The Race For Horizon • Source: Shutterstock

More from Deals

More from Business